The missing Form 10-Q covers the quarter ended June 30. Nasdaq may grant up to 180 days if it accepts SolarMax's plan, extending the deadline to Feb. 16, 2027.
One RSU grant vests at year two; the other RSUs and options vest annually over four years, subject to continued employment. Options cost $5.10 per share.
The jury found noninfringement and invalidity on three claims; Cytek intends post-verdict motions on the remaining finding and $20M lost-profits award.
The proposed transaction values Elroy Air at $800M pre-money and is expected to close in Q4 2026, subject to approvals; Army work is estimated to finish in 2029.
Ownership and voting power remain unchanged; the $0.001 par value stays intact, and holders need not act as the split targets NYSE American compliance.
The options vest 25% after each employee's first anniversary, with the rest in three annual installments tied to continued employment under Nasdaq rules.
3,437,500 shares were sold, with Roth Capital holding a 30-day option for 515,625 more; expected proceeds are intended for R&D, sales and working capital.